John Leaman

Insider Reports History

Location
San Francisco, CA
Signature
/s/ John Leaman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Leaman:

Company Role Class Num Shares Value Price $ Report Date Ownership
Traws Pharma, Inc. Director Common Stock 4,058 $10,388 $2.56 12 Dec 2025 Direct
IMPEL PHARMACEUTICALS INC Chief Fin. & Business Officer Common Stock 6,944 $2,014 $0.2900 31 Dec 2022 Direct
IMPEL PHARMACEUTICALS INC Chief Fin. & Business Officer Stock Option (right to buy) 70,000 14 Feb 2023 Direct
Traws Pharma, Inc. Director Stock Option (right to purchase) 16,234 12 Dec 2025 Direct
IMPEL PHARMACEUTICALS INC Chief Fin. & Business Officer Restricted Stock Units (RSUs) 0 31 Dec 2022 Direct

Insider Reports Filed by John Leaman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TRAW Traws Pharma, Inc. 12 Dec 2025 2 $0 4 Director 16 Dec 2025, 18:23
TRAW Traws Pharma, Inc. 21 Nov 2025 1 $0 4 Director 25 Nov 2025, 18:53
TRAW Traws Pharma, Inc. 01 Oct 2025 1 $0 4 Director 14 Oct 2025, 19:03
TRAW Traws Pharma, Inc. 01 Oct 2025 0 $0 3 Director 14 Oct 2025, 19:01
/report/000120919123010245-leaman-john-harold-2023-02-14 IMPEL PHARMACEUTICALS INC 14 Feb 2023 1 $0 4 Chief Fin. & Business Officer 16 Feb 2023, 17:20
/report/000120919123001365-leaman-john-harold-2022-12-31 IMPEL PHARMACEUTICALS INC 31 Dec 2022 3 -$13,601 4 Chief Fin. & Business Officer 04 Jan 2023, 17:46
/report/000120919122005450-leaman-john-harold-2022-01-26 IMPEL NEUROPHARMA INC 26 Jan 2022 1 $0 4 Chief Fin. & Business Officer 28 Jan 2022, 16:04
/report/000120919121061281-leaman-john-harold-2021-10-19 IMPEL NEUROPHARMA INC 19 Oct 2021 1 $0 4 Chief Fin. & Business Officer 21 Oct 2021, 17:31
/report/000120919121048219-leaman-john-harold-2021-07-20 IMPEL NEUROPHARMA INC 20 Jul 2021 1 $0 4 Chief Financial Officer 26 Jul 2021, 18:00